Breaking News

BioStem Life Sciences Announces Expansion

New lab will support the research and development pipeline for the Company's growing Contract Development and Manufacturing (CDMO) business.

BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (BioStem or the Company) a leading life sciences company specializing in perinatal tissue-based allografts for use in regenerative therapies, announced the buildout of a brand-new R&D lab. Situated in the Company’s 6,100 sq. Ft., state-of-the-art, FDA registered, cGMP facility, this new lab will support the research and development pipeline for the Company’s growing Contract Development and Manufacturi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters